ICARES Medicus, Inc. (TPEX: 6612)

ICARES Medicus Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	645	605.45	511.85	393.92	362.67	419.36
Revenue Growth (YoY)	12.20%	18.29%	29.94%	8.62%	-13.52%	27.36%
Cost of Revenue	143.67	123.05	94.41	71.04	70.8	87.53
Gross Profit	501.33	482.4	417.44	322.89	291.87	331.84
Selling, General & Admin	223.25	186.31	157.23	127	116.32	122.58
Research & Development	176.09	177.45	133.08	104.87	98.25	91.16
Operating Expenses	411.05	373.84	292.73	235.03	213.36	226.29
Operating Income	90.27	108.56	124.71	87.85	78.52	105.55
Interest Expense	-11.7	-7.17	-0.58	-0.83	-0.98	-1.17
Interest & Investment Income	18.32	5.29	2.67	2.48	1.5	3.66
Earnings From Equity Investments	0.78	-1.35	-4.18	-2.17	-5.46	-
Currency Exchange Gain (Loss)	3.35	0.93	15.72	-4.81	-6.43	-1.89
Other Non Operating Income (Expenses)	4.01	4.56	5.1	3.99	2.6	2.86
EBT Excluding Unusual Items	105.04	110.82	143.44	86.51	69.74	109.02
Gain (Loss) on Sale of Investments	-0.52	2.47	-0.33	-13.32	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	4.02	-0.01
Pretax Income	104.52	113.29	143.11	73.19	73.76	109.01
Income Tax Expense	81.49	48.86	32.72	35.82	36.84	40.52
Earnings From Continuing Operations	23.03	64.43	110.39	37.37	36.93	68.49
Minority Interest in Earnings	47.32	33.3	18.52	21.23	14.98	12.53
Net Income	70.35	97.73	128.91	58.6	51.91	81.02
Net Income to Common	70.35	97.73	128.91	58.6	51.91	81.02
Net Income Growth	-49.18%	-24.19%	119.97%	12.90%	-35.93%	15.00%
Shares Outstanding (Basic)	41	38	37	37	37	37
Shares Outstanding (Diluted)	41	39	37	37	37	37
Shares Change (YoY)	10.15%	2.90%	0.74%	0.38%	0.38%	5.24%
EPS (Basic)	1.71	2.55	3.46	1.58	1.41	2.21
EPS (Diluted)	1.71	2.54	3.45	1.58	1.40	2.20
EPS Growth	-53.73%	-26.39%	117.82%	12.99%	-36.36%	9.50%
Free Cash Flow	-161.5	-96.74	97.47	33.18	62.26	-4.63
Free Cash Flow Per Share	-3.91	-2.51	2.61	0.89	1.68	-0.13
Dividend Per Share	0.182	0.182	0.909	0.455	0.091	0.455
Dividend Growth	-80.00%	-80.00%	100.02%	400.00%	-80.00%	0%
Gross Margin	77.72%	79.68%	81.56%	81.97%	80.48%	79.13%
Operating Margin	14.00%	17.93%	24.36%	22.30%	21.65%	25.17%
Profit Margin	10.91%	16.14%	25.19%	14.88%	14.31%	19.32%
Free Cash Flow Margin	-25.04%	-15.98%	19.04%	8.42%	17.17%	-1.11%
EBITDA	118.19	129.33	142.69	106.87	99.58	122.02
EBITDA Margin	18.32%	21.36%	27.88%	27.13%	27.46%	29.10%
D&A For EBITDA	27.91	20.77	17.97	19.02	21.07	16.47
EBIT	90.27	108.56	124.71	87.85	78.52	105.55
EBIT Margin	14.00%	17.93%	24.36%	22.30%	21.65%	25.17%
Effective Tax Rate	77.97%	43.13%	22.86%	48.94%	49.94%	37.17%

Source: S&P Capital IQ. Standard template. Financial Sources.